Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTR3B pseudogene 1 is a genomic DNA sequence that is homologous to the ACTR3B gene but does not encode a functional protein. Several pseudogenes related to ACTR3B exist on chromosomes 2, 4, 10, 16, 22, and Y. Pseudogenes are typically nonfunctional and do not participate in biological processes or serve as drug targets. For canonical information regarding function and clinical relevance, refer to ACTR3B (actin-related protein 3B), which is a cytoskeletal regulator but is molecularly and functionally distinct from its pseudogenes. Key Notes: - "ACTR3B pseudogene 1" is not a valid therapeutic or biological target. The correct gene for function-related or drug-targeting purposes is ACTR3B (Actin-related protein 3B). - If your interest is a protein-coding gene and not a pseudogene, use the details for ACTR3B instead. - There is no evidence in biomedical literature or databases that ACTR3B pseudogene 1 encodes a protein, is a drug target, or has disease associations. Sources clarify that ACTR3B pseudogenes exist and are nonfunctional; all known biological function and potential disease relationships pertain solely to the ACTR3B protein-coding gene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTR3B pseudogene 1 (ACTR3BP1).